Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone and Heparin in Repeated Implantation Failures
NCT01590173Phase 3Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Jan 2012
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of prednisolone and enoxaparin in Repeated Implantation Failure (RIF) (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Clinical Pregnancy Rate at 2 years. Started Jan 2012; status: completed.
02
Drugs
prednisoloneenoxaparin
03
Conditions
Repeated Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT01590173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01590173.